Should You Take Peptides? A Doctor's Evidence-Based Answer | Dr. Jordan Feigenbaum
Aug 27, 2026 · 55m
Summary
Michael Easter and Dr. Jordan Feigenbaum examine the peptide boom, distinguishing between established drugs like GLP-1s and unproven compounds like BPC-157. They highlight the lack of human clinical trials, noting that most evidence relies on animal studies or anecdotal reports. The discussion warns against unsafe sourcing from research chemical sites, which often lack quality control, and emphasizes the need for rigorous data before adopting these treatments.
Topics discussed
Intro: Therapy Gecko, Natural Causes, and Faultline Haditha promos
Origin story: How Foster Kamer suggested peptides for the podcast
The peptide boom: From long COVID to a cure-all for everything
Sourcing concerns: Bodegas, gray markets, and sketchy suppliers
Interlude: Ads for Waking Up With Ryan and Black Mother Wound
Defining peptides: Chemistry, amino acids, and the FDA Bright Line Rule
Types of peptides: GLP-1s, research chemicals, and compounding pharmacies
Popular peptides: BPC-157, TB-500, and the 'Wolverine stack'
The evidence gap: Lack of human randomized control trials
Placebo effect: Sham knee surgery studies and pain perception
Expert skepticism: Why big pharma hasn't pursued older peptides
Safety risks: Melanotan 2, melanoma, and unknown side effects
Interlude: Ads for Therapy Thursday, Natural Causes, and others
Debating the hype: Patent issues and the 'lottery ticket' analogy
Historical parallels: The Fen-Phen disaster and FDA trust issues
Quality control: Research chemicals vs. compounding pharmacies
FDA regulations: Category 2 list and industry influence on votes
Why now? Normalization of injections and the biohacking movement
Cost and access: Insurance barriers driving people to gray markets
Interlude: Ads for Therapy Thursday, Waking Up With Ryan, and others
Harm reduction: Monitoring patients who insist on using peptides
Future outlook: Will peptides become mainstream or remain a fad?
Outro: Final thoughts, credits, and podcast promotions
Listen ad-free on Castria